Anzeige
Mehr »
Login
Donnerstag, 18.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Kurze Gold-Preis-Konsolidierung zum Einstieg in diese Aktie nutzen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CSHS | ISIN: US1920031010 | Ticker-Symbol:
NASDAQ
17.04.24
15:30 Uhr
0,380 US-Dollar
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
TELESIS BIO INC Chart 1 Jahr
5-Tage-Chart
TELESIS BIO INC 5-Tage-Chart

Aktuelle News zur TELESIS BIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.04.Telesis Bio Inc. - 8-K, Current Report1
03.04.Telesis Bio Inc. - S-8, Securities to be offered to employees in employee benefit plans1
28.03.Telesis Bio Inc reports results for the quarter ended in December - Earnings Summary1
28.03.Telesis Bio GAAP EPS of -$0.61, revenue of $7M1
28.03.Telesis Bio Inc. - 8-K, Current Report-
28.03.Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results177SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced,...
► Artikel lesen
26.02.Telesis Bio Inc. - 8-K, Current Report1
26.02.Telesis Bio reports record Q4 BioXp kit sales, margin growth1
26.02.Telesis Bio announces 26.3% drop in prelim Q4 revenue1
26.02.Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results275Telesis Bio announces Q4 and full-year 2023 select preliminary financial results, highlighting strong BioXp kit sales, expanding gross margin and reduced expenseSAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE)...
► Artikel lesen
23.02.Why Is Telesis Bio (TBIO) Stock Up 29% Today?4
30.11.23Telesis Bio Inc. - 8-K, Current Report3
14.11.23Telesis Bio Inc reports results for the quarter ended in September - Earnings Summary3
13.11.23Telesis Bio GAAP EPS of -$0.37, revenue of $5.6M1
13.11.23Recap: Telesis Bio Q3 Earnings1
13.11.23Telesis Bio Inc. - 10-Q, Quarterly Report1
13.11.23Telesis Bio Reports Third Quarter 2023 Financial Results168SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the third quarter...
► Artikel lesen
10.11.23Preview: Telesis Bio's Earnings2
09.11.23Telesis Bio Inc. - 8-K, Current Report1
07.11.23Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 20231
Seite:  Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1